Title Biotech: Virus screening - Pressing need for COVID-19 testing
  Bicycle Industry: Feverish demand during COVID-19
  IC Design: Operational growth to persist in 2021 amid upgrades to 5G
  Biotech: Vaccine industry -- Favorable reimbursements for COVID-19 vaccine developers
  Passive Components
  Athletic Footwear: Buy Feng Tay
  PC downstream: Persistent student NB demand
  Optical Communication: estimate revisions for Landmark, Truelight
  TAIWAN DOUBLE GOOD (June 3-30, 2020)
  Implications of new US restrictions on Huawei in 2020 -- ppt MAY 2020
More Titles
Title:Athletic Footwear: Buy Feng Tay
Download File:Athletic Footwear industry note_200703--sinopac.pdf 
Summary:Buy Feng Tay (9910 TT) with TP at NT$200 (22x 2021F P/E) ˇV an upside of ~14% 1) Although key client Nike gave disappointing FY4Q20 (ended MAY 31) financial results and saw elevated inventory levels, we are sanguine about Nikeˇ¦s ability to take market share from other athletic brands given its higher online sales weighting (30% vs. 15-17% for Adidas) and a healthier financial structure (details in the main text). 2) Calendar year 2Q20 was likely the trough for Nike as easing lockdown measures and the reopening of Nike stores will help digest excess inventory. Nikeˇ¦s supply chain will remain in the doldrums in JUN-JUL due to weaker order volume, though we assume 3Q20 will be the trough for the supply chain.
Register online at Become Member to receive Taiwan research services. For more information, contact TaiwanResearch.com. Tel (8862) 2316-5181
©2001, 2000, 1999 SinoPac All rights reserved. Additional copyright information applies.